Blog

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Find out about the new and ongoing neuroscience clinical trials at Pacific Neuroscience Institute, addressing difficult diseases such as brain tumors.

Pacific Neuroscience Institute’s Pacific Brain Health Center, an outpatient clinic of the Providence Saint John’s Health Center in Santa Monica, CA, is the site for an IRB approved study from Evoke Neuroscience.

An antiviral and an anti-inflammatory therapy against COVID-19, and convalescent plasma are currently in clinical trials at Providence Saint John’s Health Center in Santa Monica, CA.

A new trial treatment using blood plasma donations from people who have fully recovered from COVID-19 infection may be helpful in treating other patients with COVID-19.

First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center Using Stemedica Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow Cells Published: Apr 20, 2020 Originally published: https://www.biospace.com/article/releases/first-covid-19-patient-treated-under-emergency-use-ind-at-providence-saint-john-s-health-center-using-stemedica-ischemia-tolerant-allogeneic-mesenchymal-bone-marrow-cells/ SANTA MONICA, Calif., April 20, 2020 /PRNewswire/ — A single patient, emergency Investigational New Drug (IND) use was...

Pacific Neuroscience Institute brain health specialists are striving to find a cure for Alzheimer's disease, which is the most common type of dementia. In the United States, about 5.5 million people are affected by Alzheimer's disease, and the worldwide prevalence is estimated to be as high as 24 million. Watch this video to find out about research and clinical trials at the Pacific Brain Health Center at PNI.

Pacific Neuroscience Institute offers final enrollment into important clinical trial for patients with Lewy body dementia. Find out more about this study and eligibility criteria.

Pacific Neuroscience Institute has a strong roster of clinical trials for a number of neurological conditions including brain tumor, Cushing's disease and Lewy bodies dementia. Find out more.

Find out about Pacific Neuroscience Institute's leading edge clinical trials for Lewy Bodies dementia, Cushing's disease, Alzheimer's, brain tumor and more.